
"I am glad that taking part in a trial might help others on their own cancer journey.”
This trial was looking at thalidomide and dexamethasone with or without bortezomib (Velcade) for myeloma that had come back. Everyone in this trial had already had a transplant with their own blood stem cells or bone marrow as treatment for their myeloma. This is known as an .
To have an autologous transplant, you have high dose chemotherapy followed by your own blood stem cells or bone marrow. But sometimes this doesn’t work and the myeloma comes back.
Doctors often use thalidomide and a steroid called dexamethasone to treat myeloma that has come back. Or they may use bortezomib. Bortezomib is a type of biological therapy called a proteasome inhibitor. The researchers want to find out if having all 3 drugs was better than having thalidomide and dexamethasone alone. The aims of this trial were to
Despite attempting to contact the trial team, we have been unable to get any results for this trial.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr. C. Crawley
European Foundation for Blood and Marrow Transplantation (EBMT)
Freephone 0808 800 4040
"I am glad that taking part in a trial might help others on their own cancer journey.”